Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
1990-1999
Title
Created Date
Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes
15 July 2013
13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma
07 July 2013
Growth-hormone and prolactin excess
06 July 2013
Mechanisms of antineoplastic action of somatostatin analogs
15 June 2013
Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies
12 June 2013
The potential role of somatostatin analogues in breast cancer treatment
08 June 2013
Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent
04 June 2013
Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells
03 June 2013
All-trans retinoic acid in hematological malignancies, an update
01 June 2013
A role for growth hormone and prolactin in leukaemia and lymphoma?
01 June 2013
Display #
5
10
15
20
25
30
50
100
All
Page 57 of 59
Start
Prev
50
51
52
53
54
55
56
57
58
59
Next
End
Search
Follow us...
Latest
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
Melatonin: A Potential Regulator of DNA Methylation
Somatostatin, its receptors and analogs, in lung cancer
Melatonin in Combination with Albendazole or Albendazole Sulfoxide Produces a Synergistic Cytotoxicity against Malignant Glioma Cells through Autophagy and Apoptosis
Somatostatin receptor-targeted anti-cancer therapy
Somatostatin and analogues in the treatment of cancer. A review
Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
Biology of somatostatin in breast cancer
Melatonin inhibited the progression of gastric cancer induced by Bisphenol S via regulating the estrogen receptor 1
1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line
Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme
Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition
Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
Osteogenesis from Dental Pulp Derived Stem Cells: A Novel Conditioned Medium Including Melatonin within a Mixture of Hyaluronic, Butyric, and Retinoic Acids
About melatonin - 1996
Most Read
The Di Bella Method (DBM)
All-trans-retinoic acid and cancer
About melatonin - 1996
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Bibliography
Somatostatin in oncology, the overlooked evidences
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
How effective is chemo therapy?
Vademecum
Frequently Asked Questions
Complete objective response to biological therapy of plurifocal breast carcinoma
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Declaration recommends eliminate the use of Impact factor for research evaluation
Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients